Nucleophilic addition of aliphatic amino acids to N-2-methyl-9-hydroxy-ellipticinium acetate under peroxidase-catalysed oxidative conditions : a reinvestigation and structural revision of the adducts
- 31 December 1985
- journal article
- Published by Elsevier in Tetrahedron Letters
- Vol. 26 (40), 4933-4936
- https://doi.org/10.1016/s0040-4039(00)94989-x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Regio- and stereoselective alkylation at the 3′-terminal end of ribonucleotides by N-2-methyl-9-hydroxyellipticinium acetate : an antitumor agentTetrahedron Letters, 1985
- Requirement for the presence of a 2′-α-OH group for the arylation of purine nucleosides by elliptinium acetate, an antitumour agentJournal of the Chemical Society, Chemical Communications, 1985
- Reinvestigation of the reaction of n-2-methyl-9-hydroxyellipticinium acetate with adenosine and methanol.Tetrahedron Letters, 1984
- Potential antitumor agents: synthesis and biological properties of aliphatic amino acid 9-hydroxyellipticinium derivativesJournal of Medicinal Chemistry, 1984
- Phase II study of 9-hydroxy-2N-methylellipticinium acetateEuropean Journal of Cancer and Clinical Oncology, 1984
- Unexpected regiospecific alkylation of the antitumor agent N2-methyl-9-hydroxyellipticinium acetate with N, O or S donorsTetrahedron Letters, 1983
- Antitumor Activity, Pharmacology, and Toxicity of Ellipticines, Ellipticinium, and 9-Hydroxy Derivatives: Preliminary Clinical Trials of 2-Methyl-9-Hydroxy Ellipticinium (NSC 264-137)Published by Springer Nature ,1980
- Comparative cytotoxic and antitumoral effects of ellipticine derivatives on mouse L 1210 leukemiaChemico-Biological Interactions, 1979
- Preliminary trial of 9-hydroxy-2-methyl ellipticinium (NSC 264-137) in advanced human cancersEuropean Journal of Cancer (1965), 1978
- Étude par rm13c d'alcaloïdes à squelette acridinone 9(10h) et pyrido(4,3b) carbazole(6h)Tetrahedron, 1978